(Q48484810)

11 February 2018

review article

1 reference

title

Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years. (English)

1 reference

11 February 2018

0 references

Patrick L McGeer

1

1 reference

11 February 2018

Joseph Rogers

series ordinal

2

1 reference

11 February 2018

Edith G McGeer

series ordinal

3

1 reference

11 February 2018

publication date

1 October 2016

1 reference

11 February 2018

Journal of Alzheimer's Disease

published in

1 reference

11 February 2018

volume

54

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

853-857

1 reference

11 February 2018

Immune system associated antigens expressed by cells of the human central nervous system

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Anti-inflammatory drugs and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs).

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Up-regulated production and activation of the complement system in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Inflammatory processes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160488

21 January 2018

Identifiers

0 references

1 reference

11 February 2018